{"id":"W2082207901","doi":"10.1002/ijc.24884","title":"The effects of gefitinib in tamoxifen‐resistant and hormone‐insensitive breast cancer: A phase II study","year":2009,"lang":"en","type":"article","venue":"International Journal of Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada)","funders":"National Cancer Institute; World Health Organization","keywords":"Gefitinib; Tamoxifen; Breast cancer; Medicine; Epidermal growth factor receptor; Internal medicine; Estrogen receptor; Oncology; EGFR inhibitors; Cancer; Cancer research; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005315553,0.0001183279,0.0003187481,0.0002224995,0.00005458422,0.00003016884,0.000217866,0.00003908509,0.00003730686],"category_scores_gemma":[0.0002102848,0.00007832281,0.00008046858,0.0001685281,0.0001126234,0.00009883764,0.00005040988,0.0003727376,4.133034e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004621699,"about_ca_system_score_gemma":0.0005631627,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008045979,"about_ca_topic_score_gemma":0.000687849,"domain_scores_codex":[0.9979926,0.00009361952,0.0005179473,0.0001361346,0.001063805,0.0001959248],"domain_scores_gemma":[0.9981968,0.0002702749,0.0003200147,0.000109498,0.0009776278,0.0001257969],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.02934934,0.003524448,0.06204504,0.00007674968,0.001650968,0.003191695,0.006085335,0.00005099328,0.1495894,0.0002791186,0.005256922,0.7388999],"study_design_scores_gemma":[0.02527903,0.009459881,0.947256,0.001941922,0.0001997433,0.0005213595,0.000871659,0.0001995544,0.009190813,0.0004335536,0.004476306,0.0001702016],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9784229,0.01054002,0.000008297662,0.009977785,0.0004447946,0.0003709908,0.00004145981,0.000003650587,0.0001901346],"genre_scores_gemma":[0.9927334,0.00616987,0.00002167143,0.0003840955,0.0005374139,0.00001921988,6.420618e-7,0.00001116775,0.0001225083],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8852109,"threshold_uncertainty_score":0.3193911,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01451596220724158,"score_gpt":0.4154056267011625,"score_spread":0.4008896644939209,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}